U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Guidance, Compliance, & Regulatory Information
  4. Electronic Drug Registration and Listing System (eDRLS)
  5. Registered Establishments' Report of Private Label Distributors Form FDA 2658
  1. Electronic Drug Registration and Listing System (eDRLS)

Registered Establishments' Report of Private Label Distributors Form FDA 2658

Paper Submission

This form was historically used by manufacturers reporting listing information for those private label distributors that did not elect to submit listing information directly to FDA.  This form was also used to provide updates to product listing information every June and December or at the discretion of the manufacturer, when any change occurred. 

As of June 1, 2009, FDA only accepts electronic submissions for Registration and Listing unless a waiver is granted.  To apply for a waiver from the requirement to electronically submit drug establishment registration and drug listing information, provide a written request with a complete explanation of why use of electronic means is not reasonable for you.  Submit the request to:

SPL Coordinator

U.S. Food and Drug Administration (HF-18)

Room 12B-16
5600 Fishers Lane

Rockville, MD 20857-0001

Phone:  1-888-463-6332

 

For more information, please visit Drug Registration and Listing

 

Back to Top